Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PCD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07145437
What this trial is testing

Prostate Stereotactic Radiation and Radio-induced Lymphocyte Apoptosis for Predicting Late Toxicities in Prostate Cancer (PROSTERA)

Who this might be right for
Prostate Cancer
Clinique Sainte Clotilde 220
Testing effectiveness (Phase 2)UnknownNCT05281003
What this trial is testing

Pembrolizumab Plus Chemo in Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma (Eastern Cooperative Thoracic Oncology Projects 2004, ECTOP-2004)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 128
Not applicableUnknownNCT00197379
What this trial is testing

The Effect of 0.5% Roxithromycin Lotion for Androgenetic Alopecia

Who this might be right for
Alopecia
Hamamatsu University 20
Not applicableStudy completedNCT01155115
What this trial is testing

Inflammatory and Microbiologic Markers in Sputum: Comparing Cystic Fibrosis With Primary Ciliary Dyskinesia

Who this might be right for
Cystic FibrosisPrimary Ciliary Dyskinesia
The Hospital for Sick Children 46
Early research (Phase 1)Study completedNCT03003676
What this trial is testing

A Pilot Study of Sequential ONCOS-102, an Engineered Oncolytic Adenovirus Expressing GMCSF, and Pembrolizumab in Patients With Advanced or Unresectable Melanoma Progressing After Programmed Cell Death Protein 1 (PD1) Blockade

Who this might be right for
Advanced or Unresectable Melanoma Progressing After PD1 Blockade
Targovax Oy 21
Not applicableStudy completedNCT07601685
What this trial is testing

MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study)

Who this might be right for
PeriodontitisGingivitis and Periodontal DiseasesBiomarker Discovery and Validation+1 more
Inonu University 48
Early research (Phase 1)Study completedNCT04223804
What this trial is testing

Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Participants With Human Immunodeficiency Virus (HIV)-1

Who this might be right for
Human Immunodeficiency Virus (HIV)HIV InfectionHIV-1
AbbVie 41
Large-scale testing (Phase 3)Ended earlyNCT00215943
What this trial is testing

Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD)

Who this might be right for
Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute 90
Not applicableStudy completedNCT04161313
What this trial is testing

Respiratory Function, Exercise Capacity and Peripheral Muscle Strength Among Patients With CF, PCD and Healthy Children

Who this might be right for
Primary Ciliary DyskinesiaCystic Fibrosis
Bezmialem Vakif University 76
Not applicableStudy completedNCT03494894
What this trial is testing

Bacteriological Link Between Upper and Lower Airways in Cystic Fibrosis and Primary Ciliary Dyskinesia

Who this might be right for
Cystic FibrosisPrimary Ciliary Dyskinesia
Centre Hospitalier Intercommunal Creteil 120
Not applicableStudy completedNCT05816876
What this trial is testing

Muscle Function, Exercise Capacity and Physical Activity Level in Primary Ciliary Dyskinesia and Kartagener Syndrome

Who this might be right for
Primary Ciliary Dyskinesia
Gazi University 65
Early research (Phase 1)Study completedNCT05216835
What this trial is testing

Safety and Preliminary Efficacy Assessment of AZD7789 in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

Who this might be right for
Relapsed or Refractory Classical Hodgkin Lymphoma
AstraZeneca 45
Very early researchLooking for participantsNCT06305962
What this trial is testing

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

Who this might be right for
PDL1 Gene MutationNon Small Cell Lung CancerSmall Cell Lung Cancer ( SCLC )+6 more
Radiopharm Theranostics, Ltd 30
Not applicableStudy completedNCT04702243
What this trial is testing

Defining the Genetic Etiology of Suppurative Lung Disease in Children and Adults

Who this might be right for
Primary Ciliary DyskinesiaPrimary Immune DeficiencyKartagener Syndrome
University of North Carolina, Chapel Hill 436
Large-scale testing (Phase 3)WithdrawnNCT03744247
What this trial is testing

Lenvatinib Plus PD-1 Antibody Versus Lenvtinib Alone for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University
Testing effectiveness (Phase 2)Study completedNCT04669899
What this trial is testing

Study of JTX-8064, as Monotherapy and in Combination With a PD-1 Inhibitor, in Adult Subjects With Advanced Refractory Solid Tumors

Who this might be right for
Cancer
Jounce Therapeutics, Inc. 190
Testing effectiveness (Phase 2)Active Not RecruitingNCT04626518
What this trial is testing

Substudy 03B: A Study of Immune and Targeted Combination Therapies in Participants With Second Line Plus (2L+) Renal Cell Carcinoma (MK-3475-03B/KEYMAKER-U03)

Who this might be right for
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC 370
Not applicableUnknownNCT01442350
What this trial is testing

Myocardial Affectation in Patients With Fabry Disease Without Phenotypic Manifestation. Diagnostic Value of Biomarkers

Who this might be right for
Fabry Disease, Cardiac VariantRight Ventricular Hypertrophy
Francisco Marín Ortuño 120
Not applicableTemporarily pausedNCT07242690
What this trial is testing

PET-CT Imaging With PCD-CT

Who this might be right for
Head and Neck Cancer (H&N)
Medical University of South Carolina 20
Early research (Phase 1)Study completedNCT01383733
What this trial is testing

RO5458640 in Patients With Advanced Solid Tumors

Who this might be right for
Neoplasms
Hoffmann-La Roche 54
Next Page